| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/11/2007 | CN1943689A A Chinese traditional medicinal composition for treatment of wind-heat type common cold and its preparation method |
| 04/11/2007 | CN1943682A A Chinese traditional medicinal composition for treatment of hepatitis C |
| 04/11/2007 | CN1943676A Lyrate nightshade gelatin and its preparation method and use |
| 04/11/2007 | CN1943666A A Chinese/western compound medicine for treatment of and preventing women's colpitis |
| 04/11/2007 | CN1943663A A kind of medicine for treating and preventing women's colpitis |
| 04/11/2007 | CN1943658A A Chinese traditional medicinal composition for treating acute, chronic hepatitis and preparing method |
| 04/11/2007 | CN1943656A A kind of medicine for preventing and treating diseases of common cold, epidemic cold and parotitis |
| 04/11/2007 | CN1943647A The method for preparing triterpenic acid extract from the loquat leaves |
| 04/11/2007 | CN1943646A The recipe of peptide protein for treating hepatocirrhosis ascites and big and small three Yang caused by hepatitis B virus |
| 04/11/2007 | CN1943632A A kind of medicine for treating infant cold and its preparing method |
| 04/11/2007 | CN1943624A Medicinal composition for treating common cold and its preparing method |
| 04/11/2007 | CN1943623A Medicine for treating hepatitis B |
| 04/11/2007 | CN1943616A Medicinal composition for treating impetigo herpetifomis |
| 04/11/2007 | CN1943612A Use of honeysukle flower in preparing medicine and health article for improving body immunity |
| 04/11/2007 | CN1943609A Medicinal composition with anti-virus function and its preparing method |
| 04/11/2007 | CN1943596A Medicine for eye for preventing and curing conjunctivitis and keratitis and its preparing method |
| 04/11/2007 | CN1943593A External use anti-bacteria foaming agent for gynecology |
| 04/11/2007 | CN1943592A Process for preparing anti-heat stress medicial composition for fowls and use |
| 04/11/2007 | CN1943587A Medicinal slow release agent for treating rabbit infections rhinitis and its preparing method |
| 04/11/2007 | CN1943586A Oral disintegrating tablet using roxithromycin and ambroxol hydrochloride as active component and its preparing method and use |
| 04/11/2007 | CN1943582A Foscarnet sodium composition |
| 04/11/2007 | CN1943580A New use of fumigacin type steroids in producing medicine for anti-drug fast bacteria |
| 04/11/2007 | CN1943578A Medicinal composition containing ceftriaxone sodium and lidocaine hydrochloride injection |
| 04/11/2007 | CN1943574A Method for preparing tinidazole dispersion tablet and use |
| 04/11/2007 | CN1943561A Oral disintegration tablet of prulifloxacin and its preparing method |
| 04/11/2007 | CN1943553A Oral preparation containing ceftriaxone and its preparing method |
| 04/11/2007 | CN1943539A Skin preparation composition for external use |
| 04/11/2007 | CN1943379A Honeysuckle bagged tea and its preparing method |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309416C Pharmaceutical composition |
| 04/11/2007 | CN1309414C Hydrophilic binary systems for the administration of cyclosporine |
| 04/11/2007 | CN1309412C Medicine composition for treating AIDS and preparing method thereof |
| 04/11/2007 | CN1309405C Pigment for preventing and treating foot-mouth disease of livestock and production thereof |
| 04/11/2007 | CN1309399C Compound 'Shuanghuanglian' preparation and preparing process thereof |
| 04/11/2007 | CN1309396C Extraction of canarium leaves |
| 04/11/2007 | CN1309395C Chinese medicine for treating tuberculosis |
| 04/11/2007 | CN1309392C Hyaluronic acid mediated adenoviral transduction |
| 04/11/2007 | CN1309388C Treatment of inflammatory disorders |
| 04/11/2007 | CN1309386C Kararinol tablet and its production process |
| 04/11/2007 | CN1309382C 1'-acetoxyl chavicol acetate with anti-HIV activity |
| 04/11/2007 | CN1309381C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 04/10/2007 | US7202331 For inducing immune response and administering immunotherapy |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections |
| 04/10/2007 | US7202246 Spiro-rifamycin derivatives targeting RNA polymerase |
| 04/10/2007 | US7202240 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/10/2007 | US7202221 Macrolides |
| 04/10/2007 | US7202208 Erythropoietin composition |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202085 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 04/10/2007 | US7202034 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/10/2007 | US7201925 Treatment of ungual and subungual diseases |
| 04/10/2007 | US7201909 Genetic engineering; genome dsegment containing identifying phenotype; generation immunology response |
| 04/10/2007 | US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2337269C Novel method for preparing synthesis intermediates |
| 04/10/2007 | CA2292706C Method for administering viable microorganism composition for poultry |
| 04/10/2007 | CA2237747C New process for the preparation of azithromycin |
| 04/10/2007 | CA2226880C Cyclosporin derivatives with anti-hiv effect |
| 04/10/2007 | CA2197209C Aza cyclohexapeptide compounds |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
| 04/10/2007 | CA2154023C Recombinant infectious non-segmented negative strand rna virus |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/06/2007 | CA2522632A1 Ccr5 receptor antagonist molecules |
| 04/05/2007 | WO2007037685A1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives |
| 04/05/2007 | WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same |
| 04/05/2007 | WO2007037330A1 Method for production of quinolone-containing lyophilized preparation |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007014934A3 Quinoline derivatives as antibacterial agents |
| 04/05/2007 | WO2007014934A2 Quinoline derivatives as antibacterial agents |
| 04/05/2007 | WO2007012033A9 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 04/05/2007 | WO2007006712A3 Mycoplasma subunit vaccine |
| 04/05/2007 | WO2007002172A3 Hiv-1 protease inhibitors |
| 04/05/2007 | WO2006092822A3 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chloro phenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpi pεrazine, synthesis process and uses thereof |
| 04/05/2007 | WO2006073601A3 Methods and compositions for rna interference |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078080 N4-Acylcytosine Nucleosides for Treatment of Viral Infections |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | US20070077260 Vaccines for mycoplasma bovis and methods of use |
| 04/05/2007 | US20070077247 Receptor on the surface of activated T-cells: ACT-4 |
| 04/05/2007 | CA2623387A1 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 04/05/2007 | CA2623236A1 Human monoclonal antibodies to cd70 |
| 04/04/2007 | EP1770168A2 Compositions and methods for delivery of genetic material |
| 04/04/2007 | EP1770164A2 Streptococcus pneumoniae antigens and vaccines |
| 04/04/2007 | EP1770089A1 Pyranodibenzofuran derivatives with antifungal and antibacterial activity |
| 04/04/2007 | EP1769821A1 Applicator for the delivery of topical formulations into mucosal cavities |
| 04/04/2007 | EP1769806A2 Vaccine against HPV |